IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2025 | Sep 3 8:20 PM | Schneider Eugene | Proposed Sale | 19,658 | $60.81 | $1.2M | — | View → |
| Sep 3, 2024 | Sep 3 8:02 PM | KLEIN JOSEPH III | Proposed Sale | 28,000 | $60.00 | $1.7M | — | View → |
| Sep 2, 2025 | Sep 3 12:31 AM | Joseph Wender | Proposed Sale | 33,600 | $57.49 | $1.9M | — | View → |
| Sep 2, 2025 | Sep 2 9:34 PM | Swayze Eric | Proposed Sale | 11,130 | $49.67 | $552.9K | — | View → |
| Sep 2, 2025 | Sep 2 8:42 PM | Geary Richard S | Proposed Sale | 10,000 | $50.37 | $503.7K | — | View → |
| Sep 2, 2025 | Sep 2 8:34 PM | O'NEIL PATRICK R. | Proposed Sale | 13,050 | $54.51 | $711.4K | — | View → |
| Sep 2, 2025 | Sep 2 8:13 PM | PARSHALL B LYNNE | Proposed Sale | 20,000 | $50.91 | $1.0M | — | View → |
| Aug 22, 2025 | Aug 29 5:03 PM | Diaz Allene M. | Proposed Sale | 1,427 | $42.53 | $60.7K | — | View → |
| Aug 18, 2025 | Aug 18 8:26 PM | BENNETT C FRANK | Proposed Sale | 16,000 | $43.98 | $703.6K | — | View → |
| Aug 6, 2025 | Aug 6 8:10 PM | PARSHALL B LYNNE | Proposed Sale | 10,000 | $41.93 | $419.3K | — | View → |
| Aug 5, 2025 | Aug 5 8:17 PM | Geary Richard S | Proposed Sale | 10,000 | $42.86 | $428.6K | — | View → |
| Aug 4, 2025 | Aug 4 8:02 PM | Schneider Eugene | Proposed Sale | 9,549 | $42.88 | $409.5K | — | View → |
| Jul 30, 2025 | Jul 30 8:53 PM | Monia Brett P | Proposed Sale | 2,432 | $45.00 | $109.4K | — | View → |
| Apr 16, 2025 | Apr 16 9:41 PM | Jenne Kyle | Proposed Sale | 3,016 | $28.36 | $85.5K | — | View → |
| Apr 16, 2025 | Apr 16 9:40 PM | Birchler Brian | Proposed Sale | 680 | $28.37 | $19.3K | — | View → |
| Apr 16, 2025 | Apr 16 9:38 PM | Baroldi Joseph | Proposed Sale | 3,928 | $28.40 | $111.6K | — | View → |
| Mar 11, 2025 | Mar 11 8:04 PM | Monia Brett P | Proposed Sale | 140 | $32.32 | $4.5K | — | View → |
| Feb 4, 2025 | Feb 4 10:15 PM | O'NEIL PATRICK R. | Proposed Sale | 7,372 | $32.13 | $236.9K | — | View → |
| Feb 4, 2025 | Feb 4 9:56 PM | Monia Brett P | Proposed Sale | 40,003 | $32.13 | $1.3M | — | View → |
| Feb 4, 2025 | Feb 4 9:45 PM | O'NEIL PATRICK R. | Proposed Sale | 7,372 | $32.13 | $236.9K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |